Bisacodyl

1. Bisacodyl inhibits ATP1B3 in silico.

   “cardiac glycosides, Bisacodyl, Olsalazine, and Tegoprazan might be potential therapeutics for aging by inhibiting ATP1B3.”

   In silico

   Systematic Druggable Genome-Wide Analysis Identifies Therapeutic Targets for Aging: A Mendelian Randomization Study

   Health science reports·29 Mar 2026

More on ATP1B3